Log in
Enquire now
‌

US Patent 9965585 Detection of genetic or molecular aberrations associated with cancer

Patent 9965585 was granted and assigned to The Chinese University of Hong Kong Chorus on May, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
The Chinese University of Hong Kong Chorus
The Chinese University of Hong Kong Chorus
0
Current Assignee
The Chinese University of Hong Kong Chorus
The Chinese University of Hong Kong Chorus
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
99655850
Patent Inventor Names
Peiyong Jiang0
Rossa Wai Kwun Chiu0
Yuk-Ming Dennis Lo0
Kwan Chee Chan0
Date of Patent
May 8, 2018
0
Patent Application Number
142554150
Date Filed
April 17, 2014
0
Patent Citations Received
‌
US Patent 11773440 Safe sequencing system
‌
US Patent 12006544 Safe sequencing system
0
‌
US Patent 11999949 Methods for targeted genomic analysis
0
‌
US Patent 11929148 Systems and methods for enriching for cancer-derived fragments using fragment size
0
Patent Primary Examiner
‌
Larry D Riggs, II
0
Patent abstract

Systems, apparatus, and methods are provided for determining genetic or molecular aberrations in a biological sample. Biological samples including cell-free DNA fragments are analyzed to identify imbalances in chromosomal regions, e.g., due to deletions and/or amplifications in a tumor. Multiple loci are used for each chromosomal region. Such imbalances can be used to diagnose (screen) a patient for cancer, as well as prognosticate a patient with cancer, or to detect the presence or to monitor the progress of a premalignant condition in a patient. Severity of an imbalance and the number of regions exhibiting an imbalance can be used. A systematic analysis of non-overlapping genomic segments can provide a general screening tool. A patient can be tested over time to track severity of each of one or more chromosomal regions and a number of chromosomal regions to enable screening and prognosticating, as well as monitoring of progress (e.g. after treatment).

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9965585 Detection of genetic or molecular aberrations associated with cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.